293 related articles for article (PubMed ID: 6229053)
21. Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer.
McCormick KJ; Panje WR
Cancer Immunol Immunother; 1986; 21(3):226-32. PubMed ID: 3457630
[TBL] [Abstract][Full Text] [Related]
22. Strong prostaglandin associated suppression of the proliferation of human maternal lymphocytes by neonatal lymphocytes linked to T versus T cell interactions and differential PGE2 sensitivity.
Papadogiannakis N; Johnsen SA; Olding LB
Clin Exp Immunol; 1985 Jul; 61(1):125-34. PubMed ID: 2931220
[TBL] [Abstract][Full Text] [Related]
23. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
Murray JL; Dowd J; Hersh EM
J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703
[TBL] [Abstract][Full Text] [Related]
24. The effects of prostaglandins on the proliferation of cultured human T lymphocytes.
Maca RD
Immunopharmacology; 1983 Dec; 6(4):267-77. PubMed ID: 6317610
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin sensitivity of the PHA-response of blood lymphocytes following radiation therapy for breast cancer.
Blomgren H; Hammarström S; Wasserman J; Petrini B
Radiother Oncol; 1986 Oct; 7(2):141-5. PubMed ID: 3466235
[TBL] [Abstract][Full Text] [Related]
26. Suppression of human lymphocyte responses in chronic renal failure mediated by adherent cells: analysis in serum-free media.
Kleiman KS; Zoschke DC
J Lab Clin Med; 1985 Sep; 106(3):262-8. PubMed ID: 3928781
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin synthesis during the course of limb cartilage differentiation in vitro.
Gay SW; Kosher RA
J Embryol Exp Morphol; 1985 Oct; 89():367-82. PubMed ID: 3867724
[TBL] [Abstract][Full Text] [Related]
29. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
Holdstock G; Chastenay BF; Krawitt EL
Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
[TBL] [Abstract][Full Text] [Related]
30. Effect of physical stress on sensitivity of lymphocytes to inhibition by prostaglandin E2.
Goodwin JS; Bromberg S; Staszak C; Kaszubowski PA; Messner RP; Neal JF
J Immunol; 1981 Aug; 127(2):518-22. PubMed ID: 6265552
[TBL] [Abstract][Full Text] [Related]
31. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice.
Farrell JP; Kirkpatrick CE
J Immunol; 1987 Feb; 138(3):902-7. PubMed ID: 3100619
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients.
Haim N; Meidav A; Samuelly B; Segal R; Mekori T; Robinson E
J Biol Response Mod; 1984; 3(2):219-25. PubMed ID: 6233397
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma.
Faist E; Mewes A; Baker CC; Strasser T; Alkan SS; Rieber P; Heberer G
J Trauma; 1987 Aug; 27(8):837-48. PubMed ID: 2956432
[TBL] [Abstract][Full Text] [Related]
34. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
Campbell WB; Gomez-Sanchez CE
Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E2-mediated enhancement of human plasma cell differentiation.
Lydyard PM; Brostoff J; Hudspith BN; Parry H
Immunol Lett; 1982 Mar; 4(3):113-6. PubMed ID: 6210627
[TBL] [Abstract][Full Text] [Related]
36. Effect of indomethacin on phytohemagglutinin-stimulated peripheral blood lymphocytes in thyroid autoimmune diseases.
Pacini F; Fragu P; Mariotti S; DeGroot LJ
J Clin Immunol; 1982 Oct; 2(4):335-42. PubMed ID: 6216265
[TBL] [Abstract][Full Text] [Related]
37. Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response.
Hudspith BN; Brostoff J; McNicol MW; Johnson NM
Clin Exp Immunol; 1984 Aug; 57(2):324-30. PubMed ID: 6331921
[TBL] [Abstract][Full Text] [Related]
38. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
[TBL] [Abstract][Full Text] [Related]
39. Inability of newborns' or pregnant women's monocytes to suppress pokeweed mitogen-induced responses.
Durandy A; Fischer A; Griscelli C
J Immunol; 1982 Feb; 128(2):525-9. PubMed ID: 6459380
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of prostaglandin E2 and thromboxane B2 production by human monocytes in response to interleukin-2.
Remick DG; Larrick JW; Nguyen DT; Kunkel SL
Biochem Biophys Res Commun; 1987 Aug; 147(1):86-93. PubMed ID: 3498487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
